Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Prof. Alexander Margulis: Hadassah Pediatric Plastic Surgeon and Israel Navy Seal

As his “day job,” Prof. Alex Margulis heads the Hadassah Medical Center’s Pediatric Plastic Surgery and Craniofacial Unit, where children born with birth defects or injured in terrorist attacks are given a new lease on life. At the same time, Prof. Margulis, at age 47, is still active in the Shayetet 13 Reserves, Israel’s Navy Seals Special Forces.

Specializing in sea-to-land incursions, counter-terrorism, sabotage, maritime intelligence gathering, and maritime hostage rescue, Shayetet 13 Seals enter enemy lands to carry out secret operations, stop intruding ships, and protect Israel’s coast.

About his day job, Prof. Margulis says: "I love the beauty of this profession which combines medicine and art. It's tangible and, at the end of the surgery, you can see the results."

Prof. Margulis completed his residency at Hadassah and then did a two-year fellowship at Chicago Children's Hospital, where he worked with Dr. Bruce Bauer, a world-famous plastic surgeon. As for his participation in Shayetet 13, he notes: "I wanted to be in the most challenging unit possible in the Israel Defense Forces. I believed I could cope with it and wanted to give my maximum. I've always wanted to do my most for Israel; I guess it’s a family ethic.”

With 500 beds, 19 stories (five underground) and state-of-the-art technical equipment, the Tower is the most advanced medical facility in the Middle East.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

Prof. Margulis’ grandfather, Nahum, was the only Margulis to survive the Holocaust.

Prof. Margulis’ father, Miron, was a Refusenik who fought, along with Natan Sharansky, for the right to make Aliyah to Israel. The family finally received permission to emigrate in 1977 when Alex was 10 years old.

Married to Irit, a social worker, Prof. Margulis has three children. "I'm Israeli in my bones and in my soul,” says Prof. Margulis. “My dream is still securing freedom for us by overcoming the internal problems and striving for peace."

Date: 5/6/2014

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program

At Hadassah, Four Recover, Two Tragically Perish After Light Rail Attack

Other Doctors Suggested Aborting the Baby. The Experts at Hadassah Knew Better.

Hadassah Doctor Receives International Prize for Medical Innovation

Hadassah Doctors Rescue Frostbitten Nepal Avalanche Victim

Thousands Mourn Loss of Young Israeli Hero

A Mysterious Case Sends a Family Searching for Cures, Finding Hadassah

Grateful Patients, Their Families, and Their Doctors Offer Thanks

Head of Hadassah's Hospital Addresses The Economist Health Care Forum



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America